Daily Dilution Report - Apr 24, 2026
All Events
$LAND (MC: $421M)
- New ATM program: Up to $500M of common stock to be issued under new equity distribution agreements.
- Prior ATM sales (Jan 1-Apr 23, 2026): 4.82M shares sold for $48.35M gross proceeds at a weighted-average price of $10.03/share.
$LAND (MC: $421M)
- Established two ATM programs totaling $1B for the sale of common stock.
- Company may sell shares from time to time through Virtu Americas LLC and Lucid Capital Markets, LLC.
$MGTX (MC: $759M)
- Hologen acquired 70% ownership in HNAI via Class B share subscription for a portion of its $200M upfront payment.
- Hologen acquired a minority interest in MeiraGTx Manufacturing via share purchases for a portion of its $200M upfront payment.
- Hologen holds an option to purchase additional MeiraGTx Manufacturing shares, potentially reaching 40% aggregate ownership.
$SPIR (MC: $588M)
- Private Placement (2025) sold 4.84M shares at $8.00. Also, pre-funded warrants for 156,250 shares with $0.0001 exercise price. Total $40M gross proceeds.
- Private Placements (2026 & 2024) sold 5M shares at $14.00 ($70M gross) and 833,333 shares at $12.00 ($10M gross).
- 183,550 Class A common shares issued via Restricted Stock Units (RSUs) on Feb 4, 2025.
$DVLT (MC: $207M)
- Direct Offering: 75.9M shares of Common Stock issued as acquisition consideration for $50M, no cash proceeds to company.
- Convertible Notes: 5.7M shares of Common Stock issuable upon conversion.
- Warrants: Up to 9.68M shares exercisable from outstanding warrants (largest tranche: 9.66M @ $5.00/share).
$DVLT (MC: $207M)
- Acquisition of Vivasor shares via issuance of 75.9M DVLT common shares.
- Transaction valued at ~$50M, implying an approximate price of $0.66 per share.
- Shares issued to Vivasor are registered for potential resale by the counterparty.
$APPS (MC: $414M)
- Amendment to existing Warrants to Purchase Common Stock.
- Suspends obligation to provide registration rights for resale of shares underlying warrants until Oct 1, 2026.
- Specific warrant terms (exercise price, shares, expiration) not disclosed in this filing.
$JCAP (MC: $1.1B)
- This Form 8-K filing (dated April 22, 2026) describes an amendment to a Credit Agreement. It details an increase in revolving credit commitments and a potential for future increases. However, it does not describe any stock dilution events such as the issuance of warrants, convertible notes, convertible preferred stock, ATM programs, equity lines, direct offerings, PIPE deals, or the reservation of shares under stock compensation plans.
$GLIBA (MC: $1.2B)
- Potential issuance of Series C Common Stock to satisfy 2030 Earnout Payment related to Quintillion acquisition.
- Amount, shares, and price to be determined based on future revenue thresholds and market price post-2030 10-K filing.
- Issuance is at company's discretion; shares to be registered for resale and are exempt from registration.